Skip to main content
2026 Annual Assembly of Hospice & Palliative Care Main banner
Conference Favorites
This is not in your schedule.
This will appear in your schedule. Click again to remove it.
Session Icons
AAHPM Abstract Award Winner
AAHPM Abstract Award Winner
HPNA Abstract Award Winner
HPNA Abstract Award Winner
Registration Required
Registration Required
Poster Icons
AAHPM Abstract Award Winner
AAHPM Abstract Award Winner
HPNA Abstract Award Winner
HPNA Abstract Award Winner

Alexandra L. McPherson, PharmD, MPH (she/her/hers)

Palliative Care Clinical Pharmacy Specialist
MWHC

Dr. McPherson received her Bachelor of Science in International Business from the University of Maryland in College Park, MD, followed by her Master of Public Health (MPH) with a dual certificate in International Health and Pharmaceutical Assessment, Management, and Policy from Boston University in Boston, MA. She went on to receive her Doctor of Pharmacy from the University of Maryland School of Pharmacy in Baltimore, MD. Subsequently she completed a Pharmacy Practice Residency at Einstein Medical Center in Philadelphia, PA and Pain Management and Palliative Care Specialty Residency at the University of Maryland School of Pharmacy/MedStar Health.

She is currently a Palliative Care Clinical Pharmacy Specialist at MedStar Washington Hospital Center in Washington, DC, where she serves as faculty in the interdisciplinary Hospice and Palliative Medicine Fellowship program. In addition, she serves as a faculty member for the nation’s first M.S. in Medical Cannabis Science and Therapeutics (University of Maryland School of Pharmacy), and M.S. in Palliative Care (University of Maryland Graduate School) programs.

She is an active member of the American Academy of Hospice and Palliative Medicine and the Society of Pain and Palliative Care Pharmacists and has published and presented internationally on topics pertaining to pain management and palliative care. Her academic interests include early integration of palliative care in advanced illness, navigating transitions of care at the end-of-life, and the pharmacologic management of symptoms in serious illness..

Presentation(s):

Email Alexandra